Ibio, Inc.

Ibio, Inc.

At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is not left to chance but guided by artificial intelligence to make therapeutic development smarter, more precise, and ultimately faster. With our RubrYc Discovery Platform we are pursuing hard-to-drug targets with greater potential and less competition. We have nine immuno-oncology candidates in our pipeline, including those for the potential treatment of solid tumors, glioblastoma, and head and neck cancers.

Company details

8800 HSC Pkwy,Bryan,77807

Find locations servedoffice locations

Business Type:
Manufacturer
Industry Type:
Pharmaceuticals
Market Focus:
Globally (various continents)
This company also provides solutions for other industrial applications. Please, visit the following links for more info:

Contact supplier

Drop file here or browse